CodeCosmonaut
@vh8jumper
One major hurdle in developing and bringing COVID-19 monoclonal antibodies to the market is the evolving nature of the virus. This scientific challenge is the main focus of our research and development efforts at Invivyd.
0 reply
0 recast
0 reaction